The molecular basis of the action of chloroquine in porphyria cutanea tarda.
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D002738:Chloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D002850:Chromatography, Gel; D004195:Disease Models, Animal; D005260:Female; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000032:analysis / Q000201:enzymology / Q000473:pathology; D008930:Mitochondria, Liver / Q000378:metabolism; D010085:Oxidative Phosphorylation; D011164:Porphyrias / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011166:Porphyrins / Q000032:analysis / Q000097:blood / Q000652:urine; D011319:Primaquine / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D012877:Skin Manifestations; D013054:Spectrophotometry, Atomic
D011166:Porphyrins; D002738:Chloroquine; D000624:5-Aminolevulinate Synthetase; D011319:Primaquine